The benefits of adjuvant chemotherapy for early stage breast cancer must be considered in light of the potential risks and anticipated side effects. When considering a course of adjuvant chemotherapy for a patient, one should not only consider acute
No takes yet. Share an insight, caveat, or question.
Partridge et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: